MURA, PAOLA ANGELA
 Distribuzione geografica
Continente #
NA - Nord America 19.720
EU - Europa 11.660
AS - Asia 7.820
SA - Sud America 1.122
AF - Africa 204
OC - Oceania 140
Continente sconosciuto - Info sul continente non disponibili 2
Totale 40.668
Nazione #
US - Stati Uniti d'America 19.550
RU - Federazione Russa 3.798
IT - Italia 2.512
SG - Singapore 2.120
CN - Cina 1.831
PL - Polonia 1.259
HK - Hong Kong 1.182
IE - Irlanda 961
BR - Brasile 905
VN - Vietnam 828
SE - Svezia 727
KR - Corea 714
UA - Ucraina 689
DE - Germania 538
IN - India 369
FR - Francia 357
FI - Finlandia 328
GB - Regno Unito 247
JO - Giordania 200
AU - Australia 138
JP - Giappone 108
TR - Turchia 92
CA - Canada 91
AR - Argentina 85
BD - Bangladesh 73
ID - Indonesia 71
IQ - Iraq 56
ES - Italia 53
SC - Seychelles 48
BE - Belgio 45
MX - Messico 44
NL - Olanda 42
CI - Costa d'Avorio 36
EC - Ecuador 33
PK - Pakistan 29
CO - Colombia 28
ZA - Sudafrica 23
MA - Marocco 22
UZ - Uzbekistan 22
CH - Svizzera 21
VE - Venezuela 20
SA - Arabia Saudita 19
NG - Nigeria 16
PY - Paraguay 16
DZ - Algeria 15
PH - Filippine 14
RO - Romania 14
AZ - Azerbaigian 13
CL - Cile 12
EG - Egitto 11
JM - Giamaica 10
KZ - Kazakistan 9
LT - Lituania 9
TN - Tunisia 9
KE - Kenya 8
KG - Kirghizistan 8
PE - Perù 8
PT - Portogallo 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
BO - Bolivia 7
IR - Iran 7
CZ - Repubblica Ceca 6
ET - Etiopia 6
HU - Ungheria 6
TH - Thailandia 6
MD - Moldavia 5
NP - Nepal 5
PA - Panama 5
RS - Serbia 5
AL - Albania 4
DO - Repubblica Dominicana 4
MY - Malesia 4
NO - Norvegia 4
OM - Oman 4
SN - Senegal 4
BJ - Benin 3
BY - Bielorussia 3
CR - Costa Rica 3
DM - Dominica 3
GR - Grecia 3
IL - Israele 3
LB - Libano 3
PS - Palestinian Territory 3
QA - Qatar 3
SV - El Salvador 3
TW - Taiwan 3
DK - Danimarca 2
GH - Ghana 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
MK - Macedonia 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AT - Austria 1
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 40.651
Città #
Santa Clara 4.454
Ashburn 1.725
Fairfield 1.549
Singapore 1.461
Warsaw 1.249
Jacksonville 1.020
Chandler 990
Dublin 959
Hong Kong 958
San Jose 825
Woodbridge 709
Seoul 672
Cambridge 627
Seattle 574
Houston 555
Wilmington 539
Milan 478
Los Angeles 449
Beijing 423
Hefei 396
Ann Arbor 369
Buffalo 304
Ho Chi Minh City 292
Princeton 283
Florence 270
Altamura 246
Rome 241
The Dalles 237
Lawrence 222
Lauterbourg 221
Boardman 201
Boston 171
Hanoi 163
Mumbai 148
Moscow 145
Council Bluffs 138
Melbourne 137
Medford 135
Dallas 126
Tokyo 103
New York 101
Shanghai 98
San Diego 92
Munich 85
São Paulo 81
Kent 78
Helsinki 72
Naples 62
Orem 62
Paris 57
Turin 53
Da Nang 46
West Jordan 46
Frankfurt Am Main 45
Bengaluru 43
Bologna 43
Norwalk 43
Brussels 42
Izmir 42
Verona 42
Auburn Hills 41
Chicago 39
Jakarta 39
Philadelphia 38
Abidjan 36
Clifton 36
Toronto 35
Guangzhou 34
Haiphong 34
Falls Church 32
Rio de Janeiro 31
Figino 29
Chennai 27
Hillsboro 27
London 26
Palermo 25
Brooklyn 24
Baghdad 23
Turku 23
Genoa 22
Hyderabad 22
Manchester 22
Andover 21
Barcelona 21
Belo Horizonte 21
Frankfurt am Main 21
Miano 21
Denver 20
Mexico City 20
Redondo Beach 20
Tashkent 19
Tianjin 19
Phoenix 18
Amsterdam 17
Vancouver 17
Dong Ket 16
Yubileyny 16
Atlanta 15
Brescia 15
Catania 15
Totale 26.994
Nome #
Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state 415
Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins 375
Selection of PLA-polymers for the development of injectable prilocaine controlled release microparticles: Usefulness of thrmal analysis 365
Solid state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-B-cyclodextrin ternary systems 337
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 322
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 308
Combined Approach of Cyclodextrin Complexation and Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide 300
Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide 292
Development of a new delivery system consisting in "drug-in cyclodextrin- in nanostructured lipid carriers" for ketoprofen topical delivery 288
Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus 272
Amidated pectin-based wafers for econazole buccal delivery: Formulation optimization and antimicrobial efficacy estimation 247
Phase equilibria, crystallinity and dissolution rates of ibuprofen-polyethylene glycol 20000 solid dispersions 245
Solid dispersions of ibuprofen in urea. Effects of urea on dissolution 242
Bioavailability and clinical usefulness of low-strength tablets of phenytoin 236
Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen 231
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System 224
Preparation and dissolution characteristics of solid dispersions of ibuprofen in various polyethylene glycols 223
Comparative study of oxaprozin complexation with natural and chemically-modified cyclodextrins in solution and in the solid state 223
Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib 220
CHARACTERIZATION OF THE SOLID PHASES OF PARACETAMOL AND FENAMATES AT EQUILIBRIUM IN SATURATED SOLUTIONS 216
A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin 215
EFFECTS OF GRINDING WITH MICROCRYSTALLINE CELLULOSE AND CYCLODEXTRINS ON THE KETOPROFEN PHYSICOCHEMICAL PROPERTIES 214
Comparative evaluation of polymeric and waxy microspheres for combined colon delivery of ascorbic acid and ketoprofen 214
(S)-(+)-6-Methoxy-α-methyl-2-naphtaleneacetic acid and β-cyclodextrin derivatives: inclusion in aqueous media and solid phase interaction 213
Development and validation of a differential pulse polarographic method for quinolinic acid determination in human plasma and urine after solid-phase extraction: a chemometric approach 211
Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide, 209
ADSORPTIVE STRIPPING VOLTAMMETRY FOR THIOMERSAL ASSAY. 206
Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration 206
Combined use of bile acids and aminoacids to improve permeation properties of acyclovir 205
Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: A review 204
Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and L-arginine aimed to improve the drug solubility 204
DISSOLUTION PROPERTIES OF NAPROXEN IN COMBINATIONS WITH POLYVINYLPYRROLIDONE 203
A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption 203
Novel Findings about Double-Loaded Curcuminin HPbcyclodextrin-in Liposomes: Effects on the Lipid Bilayer and Drug Release 202
Characterization and evaluation of the performance of different calcium and magnesium salts as excipients for direct compression 200
Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents 198
DIFFERENTIAL SCANNING CALORIMETRY IN COMPATIBILITY TESTING OF PICOTAMIDE WITH PHARMACEUTICAL EXCIPIENTS 197
PHYSICAL CHARACTERIZATION OF PICOTAMIDE MONOHYDRATE AND ANHYDROUS PICOTAMIDE 195
COMPARATIVE STUDY OF THE INCLUSION PROPERTIES OF BETA-CYCLODEXTRINS FOR KETOPROFEN AND IBUPROFEN IN SOLUTION AND IN THE SOLID STATE 193
IMPROVEMENT OF ECONAZOLE SOLUBILITY IN MULTICOMPONENT SYSTEMS WITH CYCLODEXTRINS AND ACIDS 193
HOW EXPERIMENTAL DESIGN CAN IMPROVE THE VALIDATION PROCESS. STUDIES IN PHARMACEUTICAL ANALYSIS. 191
Taste Masking of Dexketoprofen Trometamol Orally Disintegrating Granules by High-Shear Coating with Glyceryl Distearate 190
Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation 190
EVALUATION OF TRANSCUTOL AS A CLONAZEPAM TRANSDERMAL PERMEATION ENHANCER FROM HYDROPHILIC GEL FORMULATIONS 189
CARBON-13 NMR STUDY OF NAPROXEN WITH CYCLODEXTRINS IN SOLUTION. 189
Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants 189
Development and characterization of naproxen-chitosan solid systems with improved dissolution properties 189
Comparative study on triclosan interactions in solution and in the solid state with natural and chemically modified cyclodextrins 189
THE PROPERTIES OF SOLID DISPERSIONS OF NAPROXEN IN VARIOUS POLYETHYLENE GLYCOLS 189
Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays 189
In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin. 187
Development and characterization of functionalized niosomes for brain targeting of dynorphin-B 186
Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review 186
Pharmaceutical availability of digoxin tablets 185
DISSOLUTION RATE AND THERMAL PROPERTIES OF NAPROXEN IN MIXTURES WITH AMORPHOUS OR CRYSTALLLINE DIMETHYL-BETACYCLODEXTRIN 184
THERMAL BEHAVIOR AND DISSOLUTION PROPERTIES OF NAPROXEN FROM BINARY AND TERNARY SOLID DISPERSIONS 184
INTERACTIONS OF KETOPROFEN AND IBUPROFEN WITH BETA-CYCLODEXTRINS IN SOLUTION AND IN THE SOLID STATE 183
New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs 183
New docking CFF91 parameters specific for cyclodextrin inclusion complexes 182
120) Effect of cyclodextrin complexation on theophylline release from coated polymeric matrix tablets 182
Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. 182
Assessment of artificial membranes aimed for in vitro study of drug buccal permeation using experimental design 181
Quality by design in the optimization of a nanosystem-ethosomal formulation for topical treatment of vitiligo 181
THERMAL ANALYSIS OF THE DEHYDRATION PROCESS OF CROSS-LINKED POLYVINYLPYRROLIDONE AND ITS MIXTURES WITH NAPROXEN 180
Employment of indolebutyric acid and indoleacetic acids complexed with α-cyclodextrin on cuttings rooting in Olea europaea L.cv. Leccio del Corno. Effects of concentration and treatment time 180
Development, characterization and in vivo evaluation of benzocaine-loaded liposomes 179
Physical chemical characterization of binary systems of prilocaine hydrochloride with triacetyl-b-cyclodextrin 179
Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting 179
Cyclodextrin complexation as a fruitful strategy for improving the performance of nebivolol delivery from solid lipid nanoparticles 176
Analysis of triclosan complexes with b-ciclodextrin and its water-soluble polymeric derivative 176
Development of a cyclodextrin-based mucoadhesive-thermo-sensitive in situ gel for clonazepam intranasal delivery 176
FORMULATION STUDIES ON TOPICAL PREPARATIONS OF CLONAZEPAM 175
Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers 175
Tablets of “Hydrochlorothiazide in Cyclodextrin in Nanoclay”: A New Nanohybrid System with Enhanced Dissolution Properties 175
Phase solubility, 1H NMR and molecular modelling studies of bupivacaine hydrochloride complexation with different cyclodextrin derivates 173
Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone 172
Controlled-release matrix tablets of ketoprofen 171
Development and characterization of liquisolid tablets based on mesoporous clays or silicas for improving glyburide dissolution 171
Response surface methodology in the optimization of chitosan-Ca pectinate bead formulations 171
Differential electrolytic potentiometry (DEP) with twin silver-silver sulphide membrane electrodes in micro titration of quaternary ammonium compounds 170
INTERACTION OF NAPROXEN WITH NONCRYSTALLINE ACETYL ß AND G-CYCLODEXTRINS IN THE SOLID AND LIQUID STATE 170
Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics 170
The influence of chitosan on cyclodextrin complexing and solubilizing abilities towards drugs 169
Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. 169
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use 168
PHASE-SOLUBILITY ANALYSIS AND MOLECULAR MODELING IN THE STUDY OF NAPROXEN-CYCLODEXTRIN INTERACTION. 168
Assessment of solid state interactions of naproxen with amorphous cyclodextrin derivatives by DSC 168
Development and optimization by Quality by Design strategies of frovatriptan orally disintegrating tablets for migraine management 168
COMPATIBILITY STUDY BETWEEN IBUPROXAM AND PHARMACEUTICAL EXCIPIENTS USING DIFFERENTIAL SCANNING CALORIMETRY, HOT-STAGE MICROCOPY AND SCANNING ELECTRON MICROSCOPY 167
CONTROLLED RELEASE MATRIX TABLETS OF KETOPROFEN. I 167
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques 167
Solid state characterization of glyburide-cyclodextrin co-ground products 166
1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with a-cyclodextrin in the presence of malic acid 166
Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: Effect of randomly methylated β-cyclodextrin 166
INFLUENCE OF THE PREPARATION METHOD ON THE PHYSICOCHEMICAL PROPERTIES OF BINARY SYSTEMS OF ECONAZOLE WITH CYCLODEXTRINS 166
INTERACTION OF NAPROXEN WITH CRYSTALLINE AND AMORPHOUS METHYLATED BET-CYCLODEXTRIN IN THE LIQUID AND SOLID STATE 165
Complesso di inclusione di un derivato dell'acido 4-metossii¬softalico con beta-ciclodestrina con attività antipiastrinica 165
Development and ex vivo evaluation of 5-aminolevulinic acid-loaded niosomal formulations for topical photodynamic therapy 165
Solubilization and interaction of naproxen with polyvinyl-pyrrolidone in aqueous solution and in the solid state 164
Simultaneous determination of otilonium bromide and diazepam by high performance liquid chromatography. 164
Totale 20.262
Categoria #
all - tutte 108.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.809


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021221 0 0 0 0 0 0 0 0 0 0 0 221
2021/20221.579 78 177 133 75 52 65 79 94 80 49 265 432
2022/20234.340 417 631 153 339 399 810 579 249 537 40 127 59
2023/20241.477 92 175 264 76 75 127 39 333 26 97 99 74
2024/202511.217 354 1.112 761 1.580 3.808 1.476 149 655 435 221 379 287
2025/202612.371 1.028 1.795 1.197 1.086 1.396 417 1.263 633 1.126 545 245 1.640
Totale 40.994